Dr. James Lawrence Rembert, MD

Dr. Rembert practices at John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health.

Dr. Rembert's NPI, 1124080916, was assigned on April 5, 2006. Dr. Rembert graduated from Perelman School of Medicine - Philadelphia in 2001. Dr. Rembert holds California license A81527.

Dr. Rembert's primary practice is John Muir Medical Center, Walnut Creek, at 1601 Ygnacio Valley Rd, Walnut Creek, CA 94598 in Contra Costa County. The practice phone is (925) 939-3000.

Dr. Rembert's primary practice is John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health. Dr. Rembert is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Rembert to 4 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rembert practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Rembert's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Rembert is board certified in radiation oncology by the American Board of Radiology. Dr. Rembert is licensed in California.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, cervical cancer radiation and colorectal cancer radiation among the conditions Dr. Rembert treats.

CMS data shows 2,454 Medicare services from Dr. Rembert across 20 procedure codes in 2024, for 514 Medicare patients. Medicare paid $210,741 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 514 Medicare patients who saw Dr. Rembert in 2024. The largest group is 65 to 74, with 229 patients. 75% of them have cancer, and 74% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rembert's median patient age at 69, with 43% women.

In 2024, Dr. Rembert wrote 214 Medicare Part D claims for 81 patients. 78% of them were for generic drugs. CMS names the drug for 134 of them, across 5 drugs with 11 or more claims each, at $95,987 in total drug cost. In 2023, CMS named 93 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Rembert for performance year 2024, reported as part of a group. Dr. Rembert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rembert as offering telehealth.

Dmand AI links 3 papers to Dr. Rembert, published from 2008 to 2013. The most frequent topics are Breast Neoplasms. Dr. Rembert's most frequent co-author is Karla Kerlikowske, MD.

CMS Open Payments shows 51 general payments to Dr. Rembert from 31 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 59% of the total. Brainlab, Inc. paid the most, $902.

Dmand AI lists 1 award for Dr. Rembert, most recently Chair Clinical Services in 2017.

Dr. Rembert graduated from Perelman School of Medicine - Philadelphia in 2001.

Dr. Rembert is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.